Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
68.2M
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
15.3M
-
Shares change
-
-118K
-
Total reported value, excl. options
-
$41.6M
-
Value change
-
-$327K
-
Number of buys
-
8
-
Number of sells
-
-6
-
Price
-
$2.71
Significant Holders of IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBT) as of Q3 2022
23 filings reported holding IOBT - IO Biotech, Inc. - Common Stock, par value $0.001 per share as of Q3 2022.
IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBT) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.3M shares
of 68.2M outstanding shares and own 22.47% of the company stock.
Largest 10 shareholders include Novo Holdings A/S (3.28M shares), Vivo Capital, LLC (3.02M shares), PFM Health Sciences, LP (2.16M shares), Avoro Capital Advisors LLC (2.06M shares), RA CAPITAL MANAGEMENT, L.P. (1.86M shares), Capital World Investors (1.24M shares), Samsara BioCapital, LLC (1.01M shares), Soleus Capital Management, L.P. (288K shares), Newtyn Management, LLC (100K shares), and BRIDGEWAY CAPITAL MANAGEMENT, LLC (95.9K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.